Progress in pathophysiological understanding and treatment of thrombocytopenia

Immune thrombocytopenia (ITP), thrombotic thrombocytopenic purpura (TTP), and vaccine-induced immune thrombotic thrombocytopenia (VITT) all have “thrombocytopenia” in their name, and all but congenital TTP are caused by immune mechanisms, but these conditions are quite different in their clinical fe...

Descripción completa

Detalles Bibliográficos
Autor principal: Kashiwagi, Hirokazu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2023
Materias:
Progress in Hematology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9851102/
https://www.ncbi.nlm.nih.gov/pubmed/36656456
http://dx.doi.org/10.1007/s12185-023-03542-w
Descripción
Sumario:Immune thrombocytopenia (ITP), thrombotic thrombocytopenic purpura (TTP), and vaccine-induced immune thrombotic thrombocytopenia (VITT) all have “thrombocytopenia” in their name, and all but congenital TTP are caused by immune mechanisms, but these conditions are quite different in their clinical features and pathophysiology. This review series covers recent progress in pathophysiology and treatment of these diseases, as well as a recent epoch-making clinical trial of induced pluripotent stem cells (iPSC)-derived platelets for patients with thrombocytopenia.

Ejemplares similares